Update re Sale of IM Minerals

RNS Number : 6301Q
Pathfinder Minerals Plc
22 February 2023
 

22 February 2023

 

Pathfinder Minerals Plc

("Pathfinder" or the "Company")

 

Update re Sale of IM Minerals

 

Further to Company's announcement on 1 February 2023 regarding the exercise of the option by Acumen Advisory Group LLC to acquire IM Minerals Limited ("IMM"), a wholly owned subsidiary of Pathfinder, the Company announces that the date by which the parties are required to enter into a conditional binding sale and purchase agreement (the "SPA") has been extended by mutual agreement from 21 February 2023 until 21 March 2023.

 

As previously announced, completion of the SPA will be conditional upon, inter alia, shareholder approval in line with AIM Rule 15 for the disposal of IMM. Pathfinder is considering bringing forward the General Meeting such that the transaction can complete with the minimum of disruption to the timeline. The Company will provide a further update as and when appropriate.

 

Enquiries:

Pathfinder Minerals Plc

Peter Taylor, Chief Executive Officer

Tel. +44 (0)20 3143 6748

 

Strand Hanson Limited (Nominated & Financial Adviser and Broker)

James Spinney / Ritchie Balmer / Rob Patrick

Tel. +44 (0)20 7409 3494

 

Vigo Consulting (Investor Relations)

Ben Simons / Kate Kilgallen

Tel. +44 (0)20 7390 0234

Email. pathfinderminerals@vigoconsulting.com

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPUAUPUPWPUG
UK 100

Latest directors dealings